The deterministic health profile is extremely weak, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental instability. As a 2x leveraged ETN, traditional valuation metrics like the Graham Number and Altman Z-Score are inapplicable, but the instrument exhibits significant long-term capital erosion with a 5-year change of -23.5%. While the dividend yield is high at 13.70%, the technical trend is completely bearish (0/100), suggesting the yield is a 'value trap' offset by price decay. This asset is a high-risk speculative tool rather than a stable investment.